4D Molecular Therapeutics
FDMT
FDMT
147 hedge funds and large institutions have $1.79B invested in 4D Molecular Therapeutics in 2024 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 48 increasing their positions, 38 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
147
Holders Change
+36
Holders Change %
+32.43%
% of All Funds
2.13%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
54
Increased
48
Reduced
38
Closed
18
Calls
$24.8M
Puts
$13.2M
Net Calls
+$11.5M
Net Calls Change
+$13M
Top Buyers
1 |
Goldman Sachs
New York
|
$97.4M |
2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
$57.3M |
3 |
RG
Redmile Group
San Francisco,
California
|
$40.2M |
4 |
B
Braidwell
Stamford,
Connecticut
|
$33.5M |
5 |
VA
VR Adviser
New York
|
$140M |